{
  "description": "EU EPI Annex II QRD code values",
  "_filename": "CodeSystem-300000000002.json",
  "package_name": "eu.epi.february2025",
  "date": null,
  "publisher": "European Medicines Agency",
  "jurisdiction": [ {
    "text": "European Union"
  } ],
  "content": "complete",
  "name": "EUepiannexIIcodesystem",
  "type": null,
  "experimental": "false",
  "resourceType": "CodeSystem",
  "title": "EU EPI Annex II QRD code values",
  "package_version": "1.0.0",
  "status": "active",
  "id": "3a1241d3-1aa8-49bd-b9f2-5cd2e74917fd",
  "kind": null,
  "count": 12,
  "url": "http://ema.europa.eu/fhir/CodeSystem/300000000002",
  "concept": [ {
    "code": "000000000000",
    "display": "Code for custom sub-sections (reserved)"
  }, {
    "code": "200000029850",
    "display": "ANNEX II"
  }, {
    "code": "200000029851",
    "display": "A.  MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE"
  }, {
    "code": "200000029852",
    "display": "B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE"
  }, {
    "code": "200000029853",
    "display": "Official batch release"
  }, {
    "code": "200000029854",
    "display": "C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION"
  }, {
    "code": "200000029855",
    "display": "Periodic safety update reports (PSURs)"
  }, {
    "code": "200000029856",
    "display": "D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT"
  }, {
    "code": "200000029857",
    "display": "Risk management plan (RMP)"
  }, {
    "code": "200000029858",
    "display": "Additional risk minimisation measures"
  }, {
    "code": "200000029859",
    "display": "Obligation to conduct post-authorisation measures"
  }, {
    "code": "200000029860",
    "display": "E. SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR  ,
  "caseSensitive": true,
  "version": "5.0.0"
}